Screening/lab tests offer huge savings for US healthcare system, says report
This article was originally published in Clinica
Executive Summary
A genetic test that enables improved treatment of patients with metastatic colorectal cancer could save $740m annually in costs to the US healthcare system, according to a new report promoting the benefits of screening and lab tests.